Use of Real-Life Safety Data From International Pharmacovigilance Databases to Assess the Importance of Symptoms Associated With Gadolinium Exposure

Recent scientific publications have reported cases of patients who complained from a variety of symptoms after they received a gadolinium-based contrast agent (GBCA). The aim of this study was to appreciate the importance of these clinical manifestations in the overall population by assessing the we...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahid, Imran, Joseph, Alvin, Lancelot, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Special Issue 2022-Contrast Media
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444285/
https://www.ncbi.nlm.nih.gov/pubmed/35471204
http://dx.doi.org/10.1097/RLI.0000000000000880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444285/
https://www.ncbi.nlm.nih.gov/pubmed/35471204
http://dx.doi.org/10.1097/RLI.0000000000000880

Ejemplares similares